Charles Schwab
BVS icon

Charles Schwab’s Bioventus BVS Stock Holding History

Charles Schwab’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
391,859
+17,917
+5% +$171K ﹤0.01% 2587
2026
Q1 		$3.41M Sell
373,942
-1,231
-0.3% -$10.3K ﹤0.01% 2558
2025
Q4 		$2.79M Sell
375,173
-72,030
-16% -$518K ﹤0.01% 2658
2025
Q3 		$2.99M Buy
447,203
+27,271
+6% +$189K ﹤0.01% 2651
2025
Q2 		$2.78M Sell
419,932
-28,315
-6% -$201K ﹤0.01% 2573
2025
Q1 		$4.1M Buy
448,247
+12,903
+3% +$129K ﹤0.01% 2353
2024
Q4 		$4.57M Buy
435,344
+45,182
+12% +$534K ﹤0.01% 2368
2024
Q3 		$4.66M Buy
390,162
+109,359
+39% +$946K ﹤0.01% 2409
2024
Q2 		$1.61M Buy
280,803
+95,152
+51% +$522K ﹤0.01% 2774
2024
Q1 		$965K Buy
185,651
+5,105
+3% +$24.9K ﹤0.01% 2810
2023
Q4 		$951K Buy
180,546
+3,198
+2% +$12.7K ﹤0.01% 2848
2023
Q3 		$585K Buy
177,348
+11,719
+7% +$41.1K ﹤0.01% 2990
2023
Q2 		$479K Sell
165,629
-70,716
-30% -$136K ﹤0.01% 3076
2023
Q1 		$253K Buy
236,345
+17,268
+8% +$33K ﹤0.01% 3124
2022
Q4 		$572K Sell
219,077
-8,732
-4% -$38.1K ﹤0.01% 2964
2022
Q3 		$1.59M Buy
227,809
+53,959
+31% +$422K ﹤0.01% 2643
2022
Q2 		$1.19M Buy
173,850
+3,681
+2% +$37.6K ﹤0.01% 2733
2022
Q1 		$2.4M Buy
170,169
+4,817
+3% +$64.5K ﹤0.01% 2584
2021
Q4 		$2.4M Buy
165,352
+91,669
+124% +$1.3M ﹤0.01% 2639
2021
Q3 		$1.04M Buy
73,683
+13,602
+23% +$209K ﹤0.01% 2860
2021
Q2 		$1.06M Buy
60,081
+8,662
+17% +$140K ﹤0.01% 2906
2021
Q1 		$786K Buy
+51,419
New +$732K ﹤0.01% 2929

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab's BVS Position: Q2 2026 in Review

Charles Schwab increased its Bioventus (BVS) stake by 4.8% in Q2 2026, buying an estimated $171K and bringing the position to 391,859 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

Charles Schwab first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.66M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Charles Schwab held 391,859 shares of Bioventus worth $3.7M as of Q2 2026.
  • Charles Schwab bought 17,917 Bioventus shares in Q2 2026, an estimated $171K.
  • Bioventus made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2587 holding.
  • Charles Schwab first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • Charles Schwab's Bioventus position peaked at $4.66M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.